Company: HCTI
Filing Date: 2025-04-01
Form Type: S-1
Source: 0001213900-25-027277
Chunk: 15

Company: Healthcare Triangle, Inc.
Filing Date: 2025-04-01
Form: S-1
Chunk 15
---
 our Common Stock by the selling stockholder. The selling stockholders
will receive all of the proceeds from any sales of the shares of our Common Stock offered hereby, however we will receive the proceeds
from any cash exercises of the Purchase Warrants.

<div align='center'>7

DIVIDEND POLICY</div>

We have never declared or paid any cash dividend
and do not anticipate paying any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance
operations and expand our business. Our board of directors has sole discretion whether to pay dividends. If our board of directors decides
to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus,
general financial condition, contractual restrictions and other factors that our directors may deem relevant.

<div align='center'>THE PRIVATE PLACEMENT</div>

On February 27, 2025, we entered
into Securities Purchase Agreements with the selling stockholders for the private placement of 36,190,485 Units, each Unit consisting
of (i) one share of Common Stock; (ii) a Pre-Funded Warrant to purchase one share of common stock; a Series A Warrant to purchase one
share of common stock and one Series B Warrant to purchase one share of common stock at an offering price of $0.42 per Unit (or $0.41999
per Unit in the case of Units that include pre-funded warrants). The Common Stock, the Pre-Funded Warrants and the Purchase Warrants included
in the Units and the Common Stock underlying the Pre-Funded Warrants and the Purchase Warrants are collectively referred to herein as
the “Securities” and the Securities, other than the Pre-Funded Warrants, and the Purchase Warrants shall be referred to herein
as the “Registrable Securities.” The entire transaction was priced at the market under Nasdaq rules and closed on February
28, 2025.

The initial exercise price
for both the Series A Warrants and Series B Warrants is $0.84 per share and both terminate on the fifth anniversary of the earlier of
(i) the effective date of the registration statement related to this prospectus (the “Registration Statement”) or (ii) the
date that the Registerable Securities can be sold, assigned or transferred without restriction or limitation pursuant to Rule 144 promulgated
under the 1933 Act, as amended. The Purchase Warrants became exercisable on March